1 active not recruiting, 1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Active not recruiting 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Adrenas Therapeutics Inc: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Determine Eligibility for CAH-301 (A Study of Gene Therapy for Classic Congenital Adrenal Hyperplasia (CAH) [NCT04783181]) Pre-Screening - Congenital Adrenal Hyperplasia | Completed | Adrenas Therapeutics Inc | 65 | 2021-07-01 | 2024-09-19 | |
| A Study of Gene Therapy for Classic Congenital Adrenal Hyperplasia (CAH) AAV BBP-631 - Congenital Adrenal Hyperplasia | Phase 1 / Phase 2 | Active not recruiting | Adrenas Therapeutics Inc | 8 | 2021-07-01 | 2025-12-23 |
Adrenal Hyperplasia, Congenital (2)
United States (2)